SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-24-011905
Filing Date
2024-07-03
Accepted
2024-07-03 08:02:33
Documents
1
Group Members
OCTAGON INVESTMENTS MASTER FUND LPTING JIA

Document Format Files

Seq Description Document Type Size
1 x72241sc13g.htm SC 13G 66813
  Complete submission text file 0001214659-24-011905.txt   68465
Mailing Address 654 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065
Business Address 654 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065 212-369-2829
Octagon Capital Advisors LP (Filed by) CIK: 0001839435 (see all company filings)

IRS No.: 843576791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Subject) CIK: 0001880438 (see all company filings)

IRS No.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93617 | Film No.: 241098276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)